Wynnefield Capital Inc.
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Wynnefield Capital Inc. reported 16 stock positions worth $158.0 million. Its top holding was Cadre (CDRE) at 21.1% of the portfolio, followed by Lifecore Biomedical (LFCR, 21.0%) and Natures Sunshine Prods (NATR, 19.6%). Compared with Q4 2024, it reduced 2. The biggest sale was Agnico Eagle Mines (AEM, shares −63%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001251567
- Portfolio Value
- $158.0M (Q1 2025)
- SEC Filing
- 0001104659-25-049377 ↗ filed May 15, 2025
Holdings Value
Holdings 16 stocks · $158.0M
| CDRE Cadre Holdings Inc. | 21.09% | 1,125,240 | $33.3M | Reduce -3.7% |
| LFCR Lifecore Biomedical Inc. | 20.95% | 4,703,216 | $33.1M | No change |
| NATR Natures Sunshine Prods Inc. | 19.65% | 2,473,686 | $31.0M | No change |
| AEM Agnico Eagle Mines Ltd. | 12.35% | 180,000 | $19.5M | Reduce -63.3% |
| DLHC DLH Holdings Corp. filed as DLH HLDGS CORP | 9.44% | 3,681,421 | $14.9M | No change |
| STKL Sunopta Inc. | 6.08% | 1,975,784 | $9.6M | No change |
| QRHC Quest Resource Holding Corp. | 4.50% | 2,734,349 | $7.1M | No change |
| PAAS Pan American Silver Corp. | 1.63% | 100,000 | $2.6M | No change |
| SIL Global X Silver Miners ETF | 1.25% | 50,000 | $2.0M | No change |
| SANW S&W Seed Co. | 0.99% | 223,718 | $1.6M | No change |
| TPCS Techprecision Corp. | 0.63% | 433,605 | $997K | No change |
| TLS Telos Corporation | 0.60% | 400,000 | $952K | No change |
| HGBL Heritage Global Inc. | 0.55% | 401,030 | $874K | No change |
| AVD American Vanguard Corp. | 0.14% | 50,000 | $220K | No change |
| SOTK Sono-Tek Corp. | 0.12% | 50,950 | $185K | No change |
| NNBR NN Inc. | 0.04% | 28,128 | $64K | No change |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $145.4M | NATR, CDRE, LFCR, DLHC, AEM |
| Q1 2026 | 9 | $147.5M | NATR, CDRE, DLHC, LFCR, AEM |
| Q4 2025 | 12 | $177.8M | NATR, CDRE, LFCR, DLHC, STKL |
| Q3 2025 | 15 | $166.4M | CDRE, NATR, LFCR, DLHC, STKL |
| Q2 2025 | 16 | $169.5M | LFCR, NATR, CDRE, DLHC, AEM |
| Q1 2025 | 16 | $158.0M | CDRE, LFCR, NATR, AEM, DLHC |
| Q4 2024 | 16 | $219.4M | AEM, CDRE, NATR, LFCR, DLHC |
| Q3 2024 | 17 | $224.7M | CDRE, AEM, DLHC, NATR, LFCR |
| Q2 2024 | 17 | $222.5M | CDRE, DLHC, NATR, AEM, LFCR |
| Q1 2024 | 23 | $251.7M | NATR, DLHC, CDRE, AEM, LFCR |